Federal Circuit affirms Novartis Alzheimer’s patents as obvious

05-04-2017

Federal Circuit affirms Novartis Alzheimer’s patents as obvious

tomloel / iStockphoto.com

The US Court of Appeals for the Federal Circuit has affirmed rulings by the Patent Trial and Appeal Board (PTAB) that two of Novartis’s patents are obvious.


Novartis, US Court of Appeals for the Federal Circuit, PTAB, patent, LTS Lohmann Therapie-Systeme, Noven Pharmaceuticals,

LSIPR